NSU-MD Faculty Articles
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine.
Publication Title
Cancer immunology, immunotherapy : CII
Publisher
Springer
ISSN
0340-7004
Publication Date
5-1-2010
Keywords
Animals, Antigen-Presenting Cells, Antimetabolites, Antineoplastic, Azacitidine, Blotting, Western, CD11b Antigen, Cancer Vaccines, Cell Differentiation, Cell Separation, Cytokines, Female, Flow Cytometry, Immunotherapy, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Myeloid Cells, Neoplasms, Experimental, Reverse Transcriptase Polymerase Chain Reaction
Abstract
Tumor-recruited CD11b myeloid cells, including myeloid-derived suppressor cells, play a significant role in tumor progression, as these cells are involved in tumor-induced immune suppression and tumor neovasculogenesis. On the other hand, the tumor-infiltrated CD11b myeloid cells could potentially be a source of immunostimulatory antigen-presenting cells (APCs), since most of these cells represent common precursors of both dendritic cells and macrophages. Here, we investigated the possibility of generating mature APCs from tumor-infiltrated CD11b myeloid cells. We demonstrate that in vitro exposure of freshly excised mouse tumors to DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (decitabine, AZA) results in selective elimination of tumor cells, but, surprisingly it also enriches CD45(+) tumor-infiltrated cells. The majority of "post-AZA" surviving CD45(+) tumor-infiltrated cells were represented by CD11b myeloid cells. A culture of isolated tumor-infiltrated CD11b cells in the presence of AZA and GM-CSF promoted their differentiation into mature F4/80/CD11c/MHC class II-positive APCs. These tumor-derived myeloid APCs produced substantially reduced amounts of immunosuppressive (IL-13, IL-10, PGE(2)), pro-angiogenic (VEGF, MMP-9) and pro-inflammatory (IL-1beta, IL-6, MIP-2) mediators than their precursors, freshly isolated tumor-infiltrated CD11b cells. Vaccinating naïve mice with ex vivo generated tumor-derived APCs resulted in the protection of 70% mice from tumor outgrowth. Importantly, no loading of tumor-derived APC with exogenous antigen was needed to stimulate T cell response and induce the anti-tumor effect. Collectively, our results for the first time demonstrate that tumor-infiltrated CD11b myeloid cells can be enriched and differentiated in the presence of DNA demethylating agent 5-aza-2'-deoxycytidine into mature tumor-derived APCs, which could be used for cancer immunotherapy.
DOI
10.1007/s00262-009-0786-4
Volume
59
Issue
5
First Page
697
Last Page
706
Disciplines
Medicine and Health Sciences
NSUWorks Citation
Daurkin, Irina; Eruslanov, Evgeniy; Vieweg, Johannes; and Kusmartsev, Sergei, "Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine." (2010). NSU-MD Faculty Articles. 53.
https://nsuworks.nova.edu/hpd_md_facarticles/53
